Ghisallo Capital Management »

Xilio Therapeutics shares owned by Ghisallo Capital Management

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Ghisallo Capital Management from 13F filings

Historical chart of Ghisallo Capital Management investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Ghisallo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Ghisallo Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $906k 1.3M 0.68
2021-12-31 $480k 30k 16.00

More positions owned by Ghisallo Capital Management

Baba 09/15/32 Cvt Put Convertible Bond
Nebius Group Shs Class A (NBIS)
Chpac 09/18/30 Cvt Put Convertible Bond
Fox Corp Cl B Com (FOX)
Pinga 06/11/30 Cvt Put Convertible Bond
Nio Spon Ads (NIO)
Baba 07/09/32 Cvt Put Convertible Bond
Quantum Computing (QUBT)
Quanc 10/02/30 Cvt Put Convertible Bond
AeroVironment (AVAV)
Loar Holdings Com Shs (LOAR)
Transocean Registered Shs (RIG)
Pony Ai Sponsored Ads (PONY)
Elbit Sys Ord (ESLT)
Ke Hldgs Sponsored Ads (BEKE)

View all positions for Ghisallo Capital Management

Top funds holding Xilio Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Merck & Co
Takeda Pharmaceutical
Morgan Stanley
Vanguard Group
AJU IB Investment
FMR
Geode Capital Management
Squarepoint Ops
Trustees of Columbia University in the City of New York
Renaissance Technologies
Balyasny Asset Management
State Street Corporation
Two Sigma Investments

View all funds holding Xilio Therapeutics